Ellevest Inc’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.84M | Buy |
23,577
+83
| +0.4% | +$9.58K | 0.39% | 36 |
|
|
2025
Q4 | $2.47M | Sell |
23,494
-108
| -0.5% | -$10.1K | 0.34% | 41 |
|
|
2025
Q3 | $1.98M | Buy |
23,602
+9,868
| +72% | +$813K | 0.28% | 45 |
|
|
2025
Q2 | $1.09M | Sell |
13,734
-2,259
| -14% | -$180K | 0.17% | 89 |
|
|
2025
Q1 | $1.44M | Buy |
15,993
+1,847
| +13% | +$172K | 0.1% | 74 |
|
|
2024
Q4 | $1.41M | Sell |
14,146
-2,501
| -15% | -$258K | 0.08% | 81 |
|
|
2024
Q3 | $1.89M | Sell |
16,647
-1,068
| -6% | -$127K | 0.1% | 63 |
|
|
2024
Q2 | $2.19M | Buy |
17,715
+1,111
| +7% | +$143K | 0.13% | 51 |
|
|
2024
Q1 | $2.19M | Buy |
16,604
+196
| +1% | +$24.2K | 0.14% | 50 |
|
|
2023
Q4 | $1.79M | Buy |
16,408
+533
| +3% | +$55.3K | 0.12% | 52 |
|
|
2023
Q3 | $1.63M | Buy |
15,875
+453
| +3% | +$48.8K | 0.13% | 47 |
|
|
2023
Q2 | $1.78M | Sell |
15,422
-247
| -2% | -$28K | 0.13% | 43 |
|
|
2023
Q1 | $1.67M | Buy |
15,669
+514
| +3% | +$55.5K | 0.13% | 44 |
|
|
2022
Q4 | $1.68M | Buy |
15,155
+448
| +3% | +$45.8K | 0.14% | 43 |
|
|
2022
Q3 | $1.27M | Buy |
14,707
+267
| +2% | +$23.8K | 0.12% | 48 |
|
|
2022
Q2 | $1.32M | Buy |
14,440
+27
| +0.2% | +$2.39K | 0.12% | 45 |
|
|
2022
Q1 | $1.18M | Buy |
14,413
+1,863
| +15% | +$147K | 0.1% | 51 |
|
|
2021
Q4 | $962K | Sell |
12,550
-422
| -3% | -$33.6K | 0.09% | 55 |
|
|
2021
Q3 | $974K | Buy |
12,972
+1,332
| +11% | +$101K | 0.09% | 51 |
|
|
2021
Q2 | $905K | Buy |
11,640
+1,827
| +19% | +$136K | 0.09% | 52 |
|
|
2021
Q1 | $722K | Sell |
9,813
-621
| -6% | -$45.8K | 0.09% | 62 |
|
|
2020
Q4 | $814K | Sell |
10,434
-156
| -1% | -$11.9K | 0.12% | 48 |
|
|
2020
Q3 | $838K | Buy |
10,590
+11
| +0.1% | +$862 | 0.15% | 44 |
|
|
2020
Q2 | $781K | Buy |
10,579
+1,100
| +12% | +$82.8K | 0.17% | 40 |
|
|
2020
Q1 | $696K | Buy |
9,479
+5,484
| +137% | +$431K | 0.19% | 34 |
|
|
2019
Q4 | $347K | Buy |
3,995
+527
| +15% | +$43.3K | 0.1% | 38 |
|
|
2019
Q3 | $279K | Buy |
3,468
+162
| +5% | +$13K | 0.1% | 41 |
|
|
2019
Q2 | $265K | Buy |
3,306
+501
| +18% | +$38.4K | 0.11% | 41 |
|
|
2019
Q1 | $223K | Sell |
2,805
-101
| -3% | -$7.55K | 0.11% | 45 |
|
|
2018
Q4 | $213K | Buy |
+2,906
| New | +$205K | 0.11% | 59 |
|
Other funds holding MRK
VCM
VPM
Ellevest Inc's MRK Position: Q1 2026 in Review
Ellevest Inc increased its Merck (MRK) stake by 0.35% in Q1 2026, buying an estimated $9.58K and bringing the position to 23,577 shares worth $2.84M. The position accounts for 0.39% of the portfolio, ranked #36.
Ellevest Inc first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Ellevest Inc held 23,577 shares of Merck worth $2.84M as of Q1 2026.
- Ellevest Inc bought 83 Merck shares in Q1 2026, an estimated $9.58K.
- Merck made up 0.39% of Ellevest Inc's portfolio in Q1 2026, its #36 holding.
- Ellevest Inc first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.